Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma

(2013) Kristen L. Drucker et al.   NEURO-ONCOLOGY

Kallikrein 6 is a novel molecular trigger of reactive astrogliosis

(2012) Isobel A. Scarisbrick et al.   BIOLOGICAL CHEMISTRY

Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis

(2012) Isobel A. Scarisbrick et al.   BRAIN PATHOLOGY

The complex world of oligodendroglial differentiation inhibitors

(2011) David Kremer et al.   ANNALS OF NEUROLOGY

Myelin Regeneration: A Recapitulation of Development?

(2011) Stephen P.J. Fancy et al.   Annual Review of Neuroscience

Structure, function and pathophysiology of protease activated receptors

(2011) Mark N. Adams et al.   PHARMACOLOGY & THERAPEUTICS

Functional Role of Kallikrein 6 in Regulating Immune Cell Survival

(2011) Isobel A. Scarisbrick et al.   PLoS One

Retinoid X receptor gamma signaling accelerates CNS remyelination

(2010) Jeffrey K Huang et al.   NATURE NEUROSCIENCE

Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function

(2009) Cecily E. Hamill et al.   EXPERIMENTAL NEUROLOGY

Toxic effect of blood components on perinatal rat subventricular zone cells and oligodendrocyte precursor cell proliferation, differentiation and migration in culture

(2009) Packiasamy A. R. Juliet et al.   JOURNAL OF NEUROCHEMISTRY

Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration

(2008) Isobel A. Scarisbrick et al.   BIOLOGICAL CHEMISTRY

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis

(2008) T. Kuhlmann et al.   BRAIN

Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines

(2008) Alexander G. Vandell et al.   JOURNAL OF NEUROCHEMISTRY